GABELLI FUNDS LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 13 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,370,000
-56.5%
625,0000.0%0.01%
-57.7%
Q2 2020$3,148,000
+70.0%
625,000
-50.0%
0.03%
+62.5%
Q1 2020$1,852,0001,250,0000.02%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
CVI Holdings, LLC 2,000,000$2,984,00010.48%
Context Capital Management, LLC 7,750,000$11,050,0006.27%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 4,750,000$9,690,0001.04%
TFG Asset Management GP Ltd 1,500,000$2,230,0000.39%
DeepCurrents Investment Group LLC 4,000,000$5,947,0000.29%
AQR Arbitrage LLC 5,000,000$7,484,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$4,427,0000.16%
Soros Fund Management 2,000,000$2,963,0000.15%
CSS LLC/IL 1,000,000$1,470,0000.12%
Verition Fund Management LLC 1,873,000$2,804,0000.11%
View complete list of INOVIO PHARMACEUTICALS INC shareholders